MAGIXVY Trademark

Trademark Overview


On Tuesday, August 9, 2022, a trademark application was filed for MAGIXVY with the United States Patent and Trademark Office. The USPTO has given the MAGIXVY trademark a serial number of 97541176. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 23, 2024. This trademark is owned by Glaxo Group Limited. The MAGIXVY trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
magixvy

General Information


Serial Number97541176
Word MarkMAGIXVY
Filing DateTuesday, August 9, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 15, 2022
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage, GB SG12NY

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage, GB SG12NY

Trademark Events


Event DateEvent Description
Friday, August 12, 2022NEW APPLICATION ENTERED
Monday, August 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 26, 2023ASSIGNED TO EXAMINER
Wednesday, May 31, 2023SUSPENSION LETTER WRITTEN
Wednesday, May 31, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, May 31, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 28, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 10, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, March 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 18, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, March 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED